Weill Cornell Medical College has refuted an article in The New York Times alleging that two researchers did not fully disclose that their research on CT screening for the early detection of lung cancer was partially funded by a tobacco company.
President David Skorton tells national reporters that higher education, especially in science and math, must be looked at as a problem solver and not as a separate interest group.
More than 300 Cornell volunteers helped at soup kitchens, community centers, homeless shelters and other projects, led in many instances by current students, as part of the 'Big Red in the Big Apple' celebration. (Jan. 28, 2008)
Alumni and Cornell students came together in 17 U.S. cities and in Shanghai, China, Jan. 5-6, for Cornell Cares Day, tackling community service projects and connecting with other Cornellians. (Jan. 9, 2008)
Many patients with AIDS in Haiti who received antiretroviral therapy had a one-year survival of 87 percent for adults and 98 percent for children, triple the 30 percent one-year survival of Haitian patients without the therapy, according to a study.
Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.
A substantial number of older persons are physically or mentally abused, and mistreated seniors are three times more likely to die within three years than those who are not abused, a study done for Cornell researchers.
For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.
Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.
